Video

Patient Selection for Atopic Dermatitis Therapies

Author(s):

Raj Chovatiya, MD, PhD,Elizabeth Swanson, MD

Elizabeth A. Swanson, MD, provide insight on identifying the appropriate patients for various therapeutic regimens in atopic dermatitis.

Related Videos
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
A panel of 3 experts on atopic dermatitis
Related Content
Therapeutic Inertia in Atopic Dermatitis Persists, Impacts Patient Outcomes
October 30th 2024

Therapeutic Inertia in Atopic Dermatitis Persists, Impacts Patient Outcomes

Chelsie Derman
Advances in Pediatric Eczema Highlight 2022
December 21st 2022

Advances in Pediatric Eczema Highlight 2022

Kevin Kunzmann
New Phase 3 Data Shows High Rate of Atopic Dermatitis Clearance Using Tapinarof Cream 1%
October 26th 2024

New Phase 3 Data Shows High Rate of Atopic Dermatitis Clearance Using Tapinarof Cream 1%

Tim Smith
How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care
July 12th 2022

How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care

Armand Butera
Long-Term Tralokinumab Safe, Effective After 6 Years for Atopic Dermatitis
October 25th 2024

Long-Term Tralokinumab Safe, Effective After 6 Years for Atopic Dermatitis

Tim Smith
Raj Chovatiya, MD, PhD: Pathophysiology, Diagnosis of Chronic Hand Eczema
October 24th 2024

Raj Chovatiya, MD, PhD: Pathophysiology, Diagnosis of Chronic Hand Eczema

Tim Smith
© 2024 MJH Life Sciences

All rights reserved.